Abiopharma

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

MOONLAKE IMMUNOTHERAPEUTICS SECURITIES FRAUD NOTICE: Berger Montague Informs MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Securities Fraud Lawsuit

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Dominari Holdings Inc. (NASDAQ: DOMH)

Creative Medical Technology Holdings Issues Letter to Shareholders

HCA Announces Proposed Public Offering of Senior Notes

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights

Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

Absci to Participate in Upcoming Investor Conferences

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®